Bioregenx (BRGX) Gross Margin (2023 - 2026)
Bioregenx (BRGX) posted quarterly Gross Margin of 81.72% for Q1 2026, up 291.0% year-over-year from 20.9% in Q1 2025, and down 2.14% quarter-over-quarter from 83.51% in Q4 2025.
Bioregenx (BRGX) Gross Margin (2023 - 2026) Analysis & Trends
Bioregenx's Gross Margin history runs 4 years deep, the most recent figure standing at 81.72% for Q1 2026.
- In Q1 2026, Gross Margin rose 291.0% year-over-year to 81.72%; the TTM figure through Mar 2026 stood at 81.96% (up 916.0% YoY), while the FY2025 annual figure was 81.08%, up 1734.0% from the prior year.
- Gross Margin for Q1 2026 stood at 81.72%, down from 83.51% in the prior quarter.
- The five-year high for Gross Margin was 83.68% in Q3 2025, with the low at 39.6% in Q4 2023.
- The 4-year median for Gross Margin is 71.39% (2023), against an average of 71.17%.
- Peak annual rise in Gross Margin reached 3013 bps in 2024, while the deepest fall reached 1313 bps in 2024.
- Bioregenx's Gross Margin stood at 39.6% in 2023, then surged by 76 bps to 69.73% in 2024, then rose by 20 bps to 83.51% in 2025, then declined by 2 bps to 81.72% in 2026.
- Business Quant data shows BRGX's Gross Margin at 81.72% in Q1 2026, 83.51% in Q4 2025, and 83.68% in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Veeva Systems | 39.72 Bn | 32.40 Bn | 662.02 Mn | 74.98% |
| 2 | BrightSpring Health Services | 12.19 Bn | 11.64 Bn | 492.75 Mn | 12.72% |
| 3 | Healthequity | 8.79 Bn | 8.52 Bn | 256.31 Mn | 72.27% |
| 4 | 10x Genomics | 7.31 Bn | 6.76 Bn | 112.50 Mn | 74.48% |
| 5 | Hinge Health | 7.10 Bn | 6.71 Bn | 183.95 Mn | 86.44% |
| 6 | MiniMed | 5.66 Bn | 5.36 Bn | 480.00 Mn | 57.35% |
| 7 | Waystar Holding | 4.76 Bn | 4.56 Bn | 221.99 Mn | 69.44% |
| 8 | Doximity | 4.46 Bn | 3.77 Bn | 132.93 Mn | 84.87% |
| 9 | Heartflow | 3.66 Bn | 3.28 Bn | 53.19 Mn | 83.00% |
| 10 | Bioregenx | 9.72 Mn | 9.67 Mn | 348,288.00 | 81.72% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 81.72% |
| Dec 31, 2025 | 83.51% |
| Sep 30, 2025 | 83.68% |
| Jun 30, 2025 | 78.89% |
| Mar 31, 2025 | 78.82% |
| Dec 31, 2024 | 69.73% |
| Sep 30, 2024 | 80.81% |
| Jun 30, 2024 | 64.01% |
| Mar 31, 2024 | 56.09% |
| Dec 31, 2023 | 39.60% |
| Sep 30, 2023 | 71.39% |
| Jun 30, 2023 | 67.78% |
| Mar 31, 2023 | 69.21% |